Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Reducing OGT and O-GlcNAcylation enhance the anticancer effects of oxaliplatin in SW620 metastatic colorectal cancer cells

ABSTRACT: The proteins and biological processes affected by OGT knockdown and oxaliplatin in CRC SW620 cells were identified and quantified by mass spectrometry-based proteomics (LC-TIMS-MS/MS and PEAKS Studio). We found that proteins involved in several pathways such as ribosomal biosynthesis and cell cycle process were altered by these treatments.

ORGANISM(S): Homo Sapiens (human)

SUBMITTER: Voraratt Champattanachai

PROVIDER: PXD064741 | JPOST Repository | Tue Feb 10 00:00:00 GMT 2026

REPOSITORIES: jPOST

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	Analyzed%20data.xlsx	Xlsx
	SC-1_GB1_1_7854.d.zip	Other
	SC-2_GB2_1_7855.d.zip	Other
	SC-3_GB3_1_7856.d.zip	Other
	SC_OXA-1_GB4_1_7858.d.zip	Other

Items per page:

1 - 5 of 13

Similar Datasets

Single cell analysis of SW620/SW620-TET2CD with long time clone culturing

Project description:In order to understand the single cell nature of SW620/SW620-TET2CD, we used the SW620/SW620-TET2CD clone from Day6/Day9/Day12/Day15 to start our single cell sequencing and analysis the diffference of single cell gene expression from different samples.

2024-11-01 | GSE188329 | GEO

mRNA expression profile of control and senescent human colorectal cancer cell line SW620

Project description:To reveal the difference in mRNA expression profile between non-senescent cancer cells and senescent cancer cells in colorectal cancer, CRC cell line SW620 was treated with hydrogen peroxide to induce senescent.

2023-03-14 | GSE226998 | GEO

Identification of differentially expressed miRNAs between SW480 and SW620 spheroid cultures [miRNA]

Project description:The colorectal cancer (CRC) cell line pair SW480/SW620 is an accepted model to study CRC progression and metastasis formation. Studying miRNA expression differences might allow to uncover molecular mechanisms that underlie metastasis initiation Both cell lines are derived from the same patient, but at different stages of the disease. They might show differences in tumor-initiating cell (TIC) potential.

2018-04-12 | GSE89522 | GEO

Identification of differentially expressed genes between SW480 and SW620 spheroid cultures [mRNA]

Project description:The colorectal cancer (CRC) cell line pair SW480/SW620 is an accepted model to study CRC progression and metastasis formation. Studying gene expression differences might allow to uncover molecular mechanisms that underlie metastasis initiation Both cell lines are derived from the same patient, but at different stages of the disease. They might show differences in tumor-initiating cell (TIC) potential.

2018-04-12 | GSE89523 | GEO

Expression data from SW620/sh control and SW620/shMACC1

Project description:Expression data from SW620/sh control and SW620/shMACC1

| PRJNA734527 | ENA

HT-29 and SW620

Project description:HT-29 and SW620

| PRJNA1200001 | ENA

Quantitative top-down proteomics reveals significant differences in histone proteoforms between metastatic and nonmetastatic colorectal cancer cells

Project description:As one of the leading causes of cancer deaths worldwide, colorectal cancer (CRC) development is closely associated with the accumulation of both genetic and epigenetic alterations. Many efforts have been made to investigate the role of epigenetic modifications in CRC metastasis. In this work, we present the first quantitative top-down proteomics study focusing on histone proteoforms between metastatic (SW620) and nonmetastatic (SW480) CRC cells to reveal potentially critical histone proteoforms in CRC metastasis. We isolated histone proteins from CRC cells, separated them by sodium dodecyl-sulfate (SDS)-polyacrylamide gel electrophoresis (PAGE), recovered each histone protein from the gel, and analyzed them by capillary zone electrophoresis (CZE)-tandem mass spectrometry (MS/MS). A total of 230 histone proteoforms were quantified in SW480 and SW620 cell lines, among which 34 proteoforms were significantly altered in abundance in the metastatic cells, indicating a significant transformation of histone proteoforms during metastasis. We observed a significant increase in abundance of all nine differentially expressed histone H4 proteoforms in metastatic SW620 cells compared to SW480 cells, while differentially expressed proteoforms of other histone proteins display diversified expression patterns. Additionally, two histone H2A proteoforms with a combination of N-terminal acetylation and phosphorylation were upregulated in the metastatic CRC cells. These differentially expressed histone proteoforms could be novel proteoform biomarkers of CRC metastasis.

2025-11-21 | PXD060160 | Pride

Genome-wide DNA methylation profiling of DNMT3A-knockout SW620 colorectal cancer cells.

Project description:DNA methyltransferase 3A (DNMT3A) contributes to tumor immune evasion by regulating TNF signaling and cholesterol biosynthesis in colorectal cancer cells. To characterize DNMT3A-dependent changes in the DNA methylation landscape, genome-wide DNA methylation profiling was performed in control and DNMT3A-knockdown SW620 colorectal cancer cells using the Infinium MethylationEPIC BeadChip array. Comparative analysis identified 14,390 differentially methylated regions, of which 12,059 were annotated to known genes. These methylation alterations were predominantly localized to promoter-associated regions, including TSS1500, TSS200, and 5′ untranslated regions. DNMT3A loss reduced promoter methylation at genes involved in TNFα- and IFNγ-related signaling pathways, including TNFRSF1A and TNFRSF1B. These data define the DNMT3A-dependent DNA methylation landscape in SW620 cells and support a role for DNMT3A-mediated promoter methylation in the transcriptional regulation of tumor immune signaling pathways.

2026-08-05 | GSE341873 | GEO

Exosomal phosphoproteome of SW620 cell

Project description:Phosphoproteome analysis on SW620 cells and exosomes.

2016-10-07 | PXD004079 | Pride

RNA-seq profiling of ADAM10 inhibition in DLD-1 and SW620 colorectal cancer cell lines

Project description:This study examines the transcriptomic effects of ADAM10 inhibition in two human colorectal cancer cell lines, DLD-1 and SW620. Cells were treated with vehicle control or the conformation-specific ADAM10 monoclonal antibody 1H5 for 48 hours, followed by extraction of total RNA and paired-end RNA sequencing. The dataset enables comparative analysis of ADAM10-regulated pathways across different CRC genetic backgrounds, including alterations in Notch and EGFR signaling, metabolic gene programs, and other pathways associated with tumor progression.

2026-01-19 | GSE311253 | GEO